Roche builds innovation center on Harvard campus
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Roche builds innovation centre on Harvard campus
Swiss pharmaceutical giant Roche has announced the opening of an innovation centre, also for its United States subsidiary Genentech, on Harvard University's corporate research campus in the Boston neighborhood of Allston.
This content was published on
2 minutes
Keystone-SDA
Français
fr
Roche érige un centre d’innovation sur le campus de Harvard
Original
Roche will initially lease the equivalent of 2,800 square metres, to bring together the expertise of cardiovascular, nephrology and metabolism specialists, as well as data science and artificial intelligence specialists.
The Basel-based company does not specify the amount involved, but plans to “invest in research and development over the next few years”, with the presence of up to 500 employees.
Roche stresses that it is the first company to set up on the campus of the prestigious private university in Massachusetts, and that it has a long history of collaboration with Harvard and other players in the region.
In its press release, Roche claims to have the entire pharmaceutical and diagnostics value chain in the US, with four Genentech sites covering R&D, production and distribution for its pharma division, as well as seven sites dedicated to R&D and manufacturing for Diagnostics.
The multinational employs more than 25,000 people, has invested $11 billion in the US and intends to continue investing there in the future.
Translated from French by DeepL/mga
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Swiss Abroad
Ups and downs: Swiss drivers benefit from world’s only mobile bridge
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Finland remains the happiest country in the world; Switzerland ranks 13th
This content was published on
Finland remains the happiest country in the world for the eighth year running. Switzerland is 13th, while the United States has its lowest ever ranking.
Survey finds money is biggest concern for Swiss families
This content was published on
HIgh health insurance premiums and rising prices are key concerns for Swiss families according to the latest family barometer.
FINMA director: ‘Capital strengthening of UBS could take place in stages’
This content was published on
The tightening of capital requirements for Swiss bank UBS could be introduced in stages, over several years, says FINMA Director Stefan Walter.
Swiss culture budget approved, after long disagreement over looted art
This content was published on
On Wednesday, the Swiss parliament found common ground on looted art after a long disagreement on this sensitive point in history.
Swiss parliamentarians back expansion of nitrochemical capacity to boost defence
This content was published on
The Swiss House of Representatives has backed a motion to expand the armaments company Nitrochemie in order to increase defence capabilities.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.